# Absolute Bioavailability of Reslizumab in Healthy Subjects

> **NCT01990443** · PHASE1 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 75 (actual)

## Conditions studied

- Absolute Bioavailability

## Interventions

- **DRUG:** Reslizumab IV
- **DRUG:** Reslizumab SC

## Key facts

- **NCT ID:** NCT01990443
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-12
- **Final completion:** 2014-03
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2014-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01990443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01990443, "Absolute Bioavailability of Reslizumab in Healthy Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01990443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*